Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

Afatinib is active in patients with head and neck and lung cancers

Nov. 3, 2010

Manageable toxicity seen with brivanib alaninate plus cetuximab and irinotecan in colorectal cancer

Nov. 3, 2010

Antibodies targeting LINGO-1 promote myelination in preclinical studies

Nov. 3, 2010

Azathioprine and prednisolone reduce relapse rates in neuromyelitis optica

Nov. 3, 2010

Mild toxicity and disease stabilizations seen with L19TNF-alpha in patients with cancer

Nov. 2, 2010

Effects of denosumab reported in patients with prostate cancer and bone metastases

Nov. 2, 2010

Clinical trials explore efficacy of budesonide in treating eosinophilic esophagitis

Nov. 2, 2010

Data from several studies on mitoxantrone for relapsing-remitting MS made available

Nov. 2, 2010

Rifaximin-EIR induces durable remissions in patients with Crohn's disease

Oct. 29, 2010

BETAPEDIC trial of IFN-beta-1b in juvenile patients with MS is enrolling participants

Oct. 29, 2010

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 2, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 30, 2026
CINP 2026: Gut microbiota could predict antidepressant response
BioWorld
The gut microbiota may be altered in people with depression as a result of treatment. These microorganisms reorganize differently in individuals who respond to...
Deep brain stimulation from the shallows: tomorrow’s BCI technology?
BioWorld
Deep brain stimulation (DBS) through implanted electrodes has enabled fundamentally new ways of treating certain disorders. More than 100,000 severely ill...
Ascending BCI systems deepen national security, ethical concerns
BioWorld
Ready or not, the future has arrived. Novel AI and brain-computer interface (BCI) systems are no longer confined to the realm of science fiction. As an...